To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Isolated Hepatic Perfusio… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Isolated Hepatic Perfusion for Ocular Melanoma Metastasis: Registry Data Suggests a Survival Benefit.

Journal article
Authors Roger Olofsson
Christian Cahlin
C All-Ericsson
Farida Hashimi
Jan Mattsson
Magnus Rizell
Per Lindnér
Published in Annals of surgical oncology
Volume 21
Issue 2
Pages 466-472
ISSN 1534-4681
Publication year 2014
Published at Institute of Clinical Sciences, Department of Surgery
Pages 466-472
Language en
Subject categories Surgery


Uveal melanoma is the most common primary intraocular malignancy in adults. Despite successful control of the primary tumor, metastatic disease will ultimately develop in approximately 35 % of the patients, with the liver being the most common site for metastases. These metastases are generally refractory to systemic chemotherapy, and the median survival for patients with liver metastases is about 6 months. This phase II trial reports the experience of isolated hepatic perfusion (IHP) as a treatment option.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?